BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Career Advice

  Pros and Cons: Working in Small Life Sciences Companies vs. Large Organizations

  Is your dream job with a large organization or a small company? It’s common for life sciences professionals to have a preference one way or the other when considering employment opportunities.

  April 12, 2019

   · 

  3 min read

   · 

  Porschia Parker
• 

  FDA

  Merck’s Keytruda Wins Approval for Yet Another Lung Cancer Indication

  There’s little doubt that Merck’s checkpoint inhibitor Keytruda (pembrolizumab) is about as close to a miracle drug as we get.

  April 12, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  A Clearer Vision for Gene Therapies: Gyroscope and Orbit Biomedical Merge

  Gyroscope Therapeutics, headquartered in Stevenage, UK, is merging with Ambler, Pennsylvania-based Orbit Biomedical. They will operate under the Gyroscope name and focus on gene therapies for diseases of the eye.

  April 12, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  BMS Releases Details of Failed CheckMate 451 Trial at European Lung Conference

  The combination of Opdivo and Yervoy actually fared worse than placebo, according to the data presented at the conference.

  April 12, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Done Deal: Bristol-Myers Squibb Shareholders Vote to Buy Celgene

  Although it was probably not in serious jeopardy, Bristol-Myers Squibb’s shareholders voted today to approve the acquisition of Celgene Corporation for about $74 billion.

  April 12, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Washington DC/Baltimore: Proximity, Access and DNA Alley

  It should be no surprise that the Washington, DC and Baltimore areas are considered strong for life sciences. This is BioSpace’s BioCapital Community Hotbed.

  April 12, 2019

   · 

  7 min read

   · 

  Mark Terry
• 

  Business

  Gilead and Novo Nordisk Team up to Tackle NASH

  The companies will collaborate on a clinical trial to combine Novo Nordisk’s semaglutide and Gilead’s cilofexor and firsocostat for treatment of NASH.

  April 12, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Job Trends

  The Bay Area’s Top Life Science Companies by Median Pay

  The San Francisco Business Times came out with a list of 64 major Bay Area employers and their median pay, which they then compared to their chief executives’ annual compensation.

  April 12, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  FDA Orders Safety Label Change for Addyi Regarding Alcohol Consumption

  Sprout wanted the warning regarding alcohol to be completely removed but the FDA said it must remain, although with a caveat.

  April 12, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Ketamine Appears to Repair Damaged Brain Circuits to Relieve Depression in Mice Study

  When the mice were dosed with ketamine, the effects of depression were reversed. Ketamine restored synapses in the brains of the mice.

  April 12, 2019

   · 

  2 min read

   · 

  Alex Keown